snapIoT Inc., a San Diego-based company, announces Automated AI-powered IRB Packaging and UAT Reporting feature to assemble all patient-facing visual assets and expedite the submission process for IRB and ethics approvals. Traditionally, this time-consuming process of IRB and ethics packaging is prone to human error and performed manually at the end of app development stages.
snapClinical™’s AI-powered Automated Documentation Engine creates key patient facing documentation assets for IRB Package setup and submission as well as UAT Reporting. With one single click, an AI-powered automation engine will: execute the app, go through all screens and generate screenshots, traverse all protocol flows and gather forms data information and auto-generate the needed materials within a single report. Annotations can be documented and exported to various file formats for further editing and processing. Pharma and CRO companies now have a faster, more efficient, and reliable method to help launch digitally enabled clinical trials.
“We have worked very closely with an early stage User Group comprised of many of the Top 10 Pharmaceutical and CRO companies as well as several IRB and Ethics SME’s to rapidly deploy this modern feature. Our Automated AI-powered IRB Packaging and UAT Reporting feature achieves the objectives of a better streamlined process to reduce time, costs and human error,” said Isaac Eteminan, CEO of snapIoT.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.